Share this post on:

Product Name :
CGS-35066

Search keywords :
CGS35066

drugId :
null

Target Vo:
Endothelin-converting enzyme 1

Target Vo Short Name :
ECE1

Moa_Name:
Endothelin-converting enzyme 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Favezelimab supplier
Bcl-2 Rabbit mAb In Vitro
TNFRSF10B Antibody (YA660): TNFRSF10B Antibody (YA660) is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to TNFRSF10B (7F4). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related